Joel Hockensmith

About

We are employing chemical control of DNA-dependent ATP hydrolysis to control epigenetic and chromatin remodelling as a novel protozoan therapeutic target for diseases such as malaria, amebic dysentery, Leishmaniasis and others.

Collaborators

Joel Hockensmith

Hockensmith, Joel W.

Novel antiprotozoan and anticancer compounds from antibiotic-resistant bacteria

 
William Petri

Petri, William A.

Immune mechanisms of defense against COVID-19 and enteric (diarrheal) infections